Industry

Ophthalmology is an exciting field that is constantly growing and evolving.

KOLOA, Hawaii — “I always have fun, and why is that? Because all of you make me smile. All of you make me enjoy what I do every day,” Jim Mazzo said when reflecting on his 44-year career in ophthalmology.

Business was not supposed to be the topic of my last column of 2022.

A study highlighted the growing role of industry funding in ophthalmology research, with a 203% increase between 2014 and 2020.

Better serving patient needs was the aim of the second Industry Collaborative hosted by the New England College of Optometry in Boston, where more than 100 attendees from eye care, industry, health care, media and academia met in August.

Vision care professionals who receive even small transfers of value from pharmaceutical companies, such as meals, gifts, and travel and speaking fees, are more likely to prescribe branded as opposed to generic drugs, according to a study.

All too often, the medical drug and device industry and its people are characterized as being entirely profit-driven.

In this Healio Video Perspective, Bill Carpou, CEO of Octane, previews this year’s Ophthalmology Technology Summit, including a special session for ophthalmologists on how to join industry boards.

The Vision Council released its VisionWatch market research report for the fourth quarter of 2021, which revealed that while the industry has rebounded from the challenges of 2020, end-of-year revenue remains lower than in previous years.

Let’s take a break from the dry eye disease market for a moment, shall we?